Pill Packets

Pharmaceuticals 'not doing enough' to develop new antibiotics

By: Information Daily Staff Writer
Published: Tuesday, November 19, 2013 - 17:04 GMT Jump to Comments

Pharmaceutical companies are not doing enough to develop new antibiotics following an increase in antibiotic-resistant infections worldwide, said Dr Jason Clark, Chief Technology Officer of Novolytics.

Speaking exclusively to the Information Daily at Global Health 2013: Rise of the Resistance, Dr Clark explained how Novolytics aims to exploit the therapeutic potential offered by bacteriophages (“phages”) in a way which is commercially viable and attractive to its investors.

A bacteriophage is a virus that infects bacteria and is seen as a possible future treatment against strains of antibiotic-resistant infections. It is understood that phages kill one quarter of the bacteria on the planet every day.

Dr Clark said: “Bacteriophages are everywhere. They're on your skin, in your food, phages are in your stomach, you probably have more phages in your body than you do bacteria and they're completely inert in humans and other mammals so they're very safe”.

Dr Clark explained precisely how his company is treating antibiotic resistant infections: “At our company we use bacteriophages to treat antibiotic resistant infections, bacteria phages are viruses which only infect bacteria, what they do is infect and kill bacteria such as MRSA and E coli”.

Right now the company are in the stages of research just before Phase 1 clinical trials. All three phases of the clinical trials would take almost ten years to be completed, even though phases 1 and 2 are relatively quick.

“There’s quite a large body of literature suggesting that they are very safe and that they do work, the issue is that they have not been purified in a manner that’s consistent with western regulatory standards.

"They have not been taken through the full clinical trials process and that’s what we are trying to do", said Dr Clark.

Comments

Latest

Local and national government agencies, businesses, higher education and the third sector are wasting billions…

In local government embracing open data is often a matter of compulsion or driven by the need to reduce FOI requests.…

As Scotland voted to stay in the UK, English cities and regions argued for more power - and the PM said he agreed:…

The introduction of different regulators and new competition rules are making collaboration in the NHS increasingly…

Our fair trade organisation, Traidcraft, has just launched its Justice Campaign. The campaign is calling for the…

The impact of chronic illnesses continues to rise in the United Kingdom. The World Health Organisation estimates…

RealityBites - The National Healthcare Conversation moves to Tuesdays and takes on the future of general practice.…

Britain has a habit of funding new museums and attractions, when it would often do better to support and renovate…

Do you do digital? Take the test

The Information Daily is collaborating with Socitm to research organisations' commitment to and capability for a digital future.

Take the test

View Results

If you have already taken the test, you may view the latest detailed results by entering your email address below


Headline results so far: Results from 108 users

Corporate commitment: 46%
0%
100%
50%
Digital capability: 53%
0%
100%
50%

The best way to track developments in UK’s local authorities is through the work of local journalists. A…

It makes sense for CCGs to have a bigger role in commissioning but they will need the oversight of NHS England…

The quarterly Enterprise Tracker report produced by RBS in association with UnLtd shows that UK social entrepreneurs,…

There needs to be a grown-up consultation with the public about how patient data is handled, says Tony Davis,…